ABT vs BSX
Abbott Laboratories · Boston Scientific Corporation
Relative return (rebased to 100)
Key stats
| Metric | ABT | BSX |
|---|---|---|
| Price | $100.10 | $42.40 |
| Market Cap | $174.36B | $61.45B |
| P/E | 26.73 | 21.25 |
| P/B | 3.35 | 2.46 |
| P/S | 3.93 | 3.06 |
| ROE | 12.5% | 11.6% |
| Net Margin | 14.7% | 14.4% |
| Gross Margin | — | 69.0% |
| Revenue Growth | 5.7% | 19.9% |
| Dividend Yield | 2.40% | — |
| EPS | $3.75 | $2.00 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.